Tylenol maker Kenvue ousts CEO amid board's strategic review

Go back to Tylenol maker Kenvue ousts CEO amid board's strategic review
(NYSE: KVUE) Delayed: 18.95 -0.18 (0.94%)
Previous Close $19.13    52 Week High
Open $19.18    52 Week Low
Day High $19.19    P/E N/A 
Day Low $18.84    EPS
Volume 18,570,264